| 000 | 01742 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516113730.0 | ||
| 264 | 0 | _c20130306 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0045492 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEngesæter, Birgit | |
| 245 | 0 | 0 |
_aDacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma. _h[electronic resource] |
| 260 |
_bPloS one _c2012 |
||
| 300 |
_ae45492 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMelanoma _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xagonists |
| 650 | 0 | 4 | _aTumor Stem Cell Assay |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aEngebraaten, Olav | |
| 700 | 1 | _aFlørenes, Vivi Ann | |
| 700 | 1 | _aMælandsmo, Gunhild Mari | |
| 773 | 0 |
_tPloS one _gvol. 7 _gno. 9 _gp. e45492 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0045492 _zAvailable from publisher's website |
| 999 |
_c22151521 _d22151521 |
||